[144] Dorman Products, Inc. New SEC Filing

Rhea-AI Filing Summary

Dorman Products, Inc. (DORM) filed a Form 144 disclosing a planned discretionary sale by an affiliate/insider of 820 common shares—valued at approximately $100,040—through Fidelity Brokerage Services on or about 28 July 2025. The stake equals roughly 0.003 % of the company’s 30,511,174 shares outstanding and therefore is immaterial to float and daily trading volume.

The shares originated from restricted-stock vesting on 6 Mar 2022 and constitute non-cash compensation. The filer reports no other sales in the prior three months and certifies lack of undisclosed adverse information. While insider transactions can signal sentiment, the modest dollar amount and percentage suggest limited market impact.

Insights

Securities Analyst

TL;DR: Minor insider sale (820 shares, $100k) is immaterial; neutral signal for DORM investors.

The Form 144 covers a prospective sale amounting to 0.003 % of outstanding shares, far below thresholds that typically trigger liquidity or signaling concerns. The shares stem from routine equity compensation, not open-market purchases, lessening any negative interpretation. Given Dorman’s average daily volume (~100k-plus shares), execution should have negligible price impact. No pattern of recent sales is disclosed, supporting a neutral view. Overall, the filing is informational rather than market-moving.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	820	100040.00	30511174	07/28/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/06/2022	Restricted Stock Vesting	Issuer			820	03/06/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many DORM shares are being sold under this Form 144?

820 common shares are slated for sale.

What is the estimated dollar value of the planned insider sale?

The aggregate market value is approximately $100,040.

When is the proposed sale date for the DORM shares?

The filing lists an approximate sale date of 28 July 2025.

What percentage of Dorman Products’ shares outstanding does 820 shares represent?

About 0.003 % of the 30,511,174 shares outstanding.

How were the shares originally acquired by the insider?

They were obtained via restricted-stock vesting on 6 Mar 2022 as compensation.